Cytek Biosciences CTKB
NASDAQ CTKB
$5.91 +0.14 (+2.52%)
As of: Sep 30, 2026 · 3:49 PM EDT

Cytek Biosciences (CTKB) EV to EBIT (2021 - 2022)

Updated

Cytek Biosciences' EV to EBIT came in at 1132.89 for Q2 2022, up 492.0% from the prior quarter.

Analysis

Cytek Biosciences (CTKB) EV to EBIT (2021 - 2022) Analysis & Trends

Over the trailing twelve months to Jun 30, 2022, Cytek Biosciences reported EV to EBIT of -9.88; for FY2021, it came in at 96.95.

  • Business Quant data shows CTKB's EV to EBIT at 191.36 (Q1 2022), 96.95 (Q4 2021) and 123.59 (Q3 2021) in the three quarters before Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Cytek Biosciences 748.70 Mn 424.97 Mn 28.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 1,132.89
Mar 31, 2022 191.36
Dec 31, 2021 96.95
Sep 30, 2021 123.59
API Access

Cytek Biosciences EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CTKB&period=max&api_key=YOUR_API_KEY